CBDMD, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8711 USD | -3.21% |
|
-12.89% | -16.24% |
| 04-02 | CbdMD, Inc. Appoints Brad Whitford as Chief Accounting Officer, Treasurer and Secretary | CI |
| 03-29 | Transcript : CbdMD, Inc. - Shareholder/Analyst Call |
| Sales 2024 * | 22.51M 1.8B | Sales 2025 * | 27.02M 2.16B | Capitalization | 2.65M 212M |
|---|---|---|---|---|---|
| Net income 2024 * | -6M -480M | Net income 2025 * | -2M -160M | EV / Sales 2024 * | 0.12 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.1 x |
| P/E ratio 2024 * |
-0.4
x | P/E ratio 2025 * |
-1.81
x | Employees | 52 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 78.81% |
More Fundamentals
* Assessed data
More news
Latest transcript on cbdMD, Inc.
More press releases
| 1 day | -3.21% | ||
| 1 week | -12.89% | ||
| Current month | -6.33% | ||
| 1 month | -13.75% | ||
| 3 months | +12.95% | ||
| 6 months | -4.27% | ||
| Current year | -16.24% |
1 week
0.80
1.02
1 month
0.721.14
Current year
0.641.34
1 year
0.562.35
3 years
0.56179.55
5 years
0.56325.80
10 years
0.56325.80
| Managers | Title | Age | Since |
|---|---|---|---|
T. Kennedy
CEO | Chief Executive Officer | 45 | 30/09/20 |
Zeb Booker
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/18 |
Sibyl Swift
CTO | Chief Tech/Sci/R&D Officer | 43 | 28/04/21 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Bakari Sellers
BRD | Director/Board Member | 39 | 28/02/17 |
Scott Stephen
CHM | Chairman | 58 | 18/04/19 |
William Raines
BRD | Director/Board Member | 64 | 18/04/19 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.71% | 35 M€ | +18.97% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 0.8711 | -3.21% | 59,960 |
| 25/04/24 | 0.9 | 0.00% | 34,257 |
| 24/04/24 | 0.9 | -1.11% | 28,602 |
| 23/04/24 | 0.9101 | -6.66% | 97,486 |
| 22/04/24 | 0.975 | -2.50% | 45,800 |
Delayed Quote Nyse, April 26, 2024 at 09:10 pm
More quotes
cbdMD, Inc. produces and distributes cannabidiol (CBD) products. The Company owns and operates CBD brands cbdMD, Paw CBD and cbdMD Botanicals. Its cbdMD brand of products includes a range of premium every day and functional CBD products, including tinctures; gummies; topicals; capsules; drink mixes; and sleep, focus and calming aids.Its Paw CBD brand of products includes a line of veterinarian-formulated products including tinctures, chews, topicals products in varying strengths and formulas. Its cbdMD Botanicals brand of beauty and skincare products features facial oil and serum, toners, moisturizers, clear skin, facial masks, exfoliants and body care stock-keeping units (SKU). cbdMD, Paw CBD and cbdMD Botanicals products are distributed through its e-commerce websites, third party ecommerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers. Its products are sold through www.cbdmd.com, www.pawcbd.com, and cbdmdbotanicals.com Websites.
Sector
Pharmaceuticals
Calendar
14/05/2024
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
D+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.8711
USD
Average target price
2
USD
Spread / Average Target
+129.59%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -16.24% | 2.65M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- YCBD Stock
